NCT06651515View on ClinicalTrials.gov

A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2028

Conditions
Diabetes Mellitus Type 1
Interventions
BIOLOGICAL

Allogeneic Pancreatic Endocrine Cell Clusters

Allogeneic Pancreatic Endocrine Cell Clusters

Trial Locations (2)

15213

UPMC Presbyterian Shadyside, Pittsburgh

19104

University of Pennsylvania, Philadelphia

Sponsors

Lead Sponsor

Seraxis
All Listed Sponsors
lead

Seraxis

INDUSTRY

NCT06651515 - A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia | Biotech Hunter | Biotech Hunter